chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Rash erythematous
Clinical narrative: Red rash on torso, neck, back and injected upper arm; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Body aches) and RASH ERYTHEMATOUS (Red rash on torso, neck, back and injected upper arm) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Clindamycin). Concomitant products included CETIRIZINE HYDROCHLORIDE (CETRIZINE), CUCURBITA PEPO SEED OIL, LYCOPENE, OENOTHERA BIENNIS OIL, SELENIUM, SERENOA REPENS, ZINC (SAW PALMETTO COMPLETE) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced CHILLS (Chills) and MYALGIA (Body aches). On 07-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on torso, neck, back and injected upper arm). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), MYALGIA (Body aches) and RASH ERYTHEMATOUS (Red rash on torso, neck, back and injected upper arm) outcome was unknown. Not Provided          other concomitant medications include Multivitamins.   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypokinesia, Injection site pain, Myalgia, Vaccination site pain
Clinical narrative: my vision was extremely blurry and lasted for probably about 15 hours; Could not move my left arm; arm where she received the injection was swollen; arm where she received the injection was sore; if she presses the area where she got injected it still has that little bit of tenderness; headache; would use her right arm to move her left arm because of the soreness; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore) and INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore), INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness), HEADACHE (headache) and MYALGIA (would use her right arm to move her left arm because of the soreness). At the time of the report, VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore), INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness), HEADACHE (headache) and MYALGIA (would use her right arm to move her left arm because of the soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-071310 (Linked Report).; Sender's Comments:  MOD21-071310:crosslink
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vision blurred
Clinical narrative: my vision was extremely blurry and lasted for probably about 15 hours; Could not move my left arm; arm where she received the injection was swollen; arm where she received the injection was sore; if she presses the area where she got injected it still has that little bit of tenderness; headache; would use her right arm to move her left arm because of the soreness; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore) and INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore), INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness), HEADACHE (headache) and MYALGIA (would use her right arm to move her left arm because of the soreness). At the time of the report, VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore), INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness), HEADACHE (headache) and MYALGIA (would use her right arm to move her left arm because of the soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-071310 (Linked Report).; Sender's Comments:  MOD21-071310:crosslink
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site reaction
Clinical narrative: Severe Adverse Reaction; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and VACCINATION SITE REACTION (Severe Adverse Reaction) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and VACCINATION SITE REACTION (Severe Adverse Reaction). At the time of the report, DIZZINESS (Dizziness) and VACCINATION SITE REACTION (Severe Adverse Reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Product includes Anti-depressants(not sure) Treatment information was not provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle soreness) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history information was given by the reporter.  Concomitant products included EZETIMIBE (ZETIA), CANDESARTAN, TICAGRELOR (BRILINTA), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), FINASTERIDE (PROSCAR) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced MYALGIA (Muscle soreness). On 04-Feb-2021, MYALGIA (Muscle soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product used included zetia, candesartan, brilinta, aspirin 81 mg, proscar and Lipitor.  No treatment medications provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: Live follow up received on 22-May-2021. No new information was updated.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in the arm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Fractured ribs (3 cracked ribs on the left side). Concomitant products included LIDOCAINE for an unknown indication.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in the arm). At the time of the report, VACCINATION SITE PAIN (pain in the arm) outcome was unknown. Not Provided
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: pains; soreness at place at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pains) and VACCINATION SITE PAIN (soreness at place at the injection) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (pains) and VACCINATION SITE PAIN (soreness at place at the injection). At the time of the report, PAIN (pains) and VACCINATION SITE PAIN (soreness at place at the injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Email with outcome
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient 2nd dose administered 5 days early; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient 2nd dose administered 5 days early) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient 2nd dose administered 5 days early). On 06-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient 2nd dose administered 5 days early) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Big hive/ Covid arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Big hive/ Covid arm at the injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (Big hive/ Covid arm at the injection site). The patient was treated with CETIRIZINE at an unspecified dose and frequency; IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency. On 12-Feb-2021, VACCINATION SITE URTICARIA (Big hive/ Covid arm at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use information was not provided by reporter   This case was linked to MOD-2021-069744 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up information received(form)  contains non-significant information; Sender's Comments:  MOD-2021-069744:Second dose of vaccine case
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This spontaneous case was reported by a health care professional and describes the occurrence of CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included Thyroid cancer.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced CHILLS (chills). On 09-Mar-2021, CHILLS (chills) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications are listed as thyroid medication, high blood pressure medication, and asthma medication.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Limb discomfort
Clinical narrative: can barely move arm; excruciating pain at bottom part of the elbow; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (can barely move arm) and ARTHRALGIA (excruciating pain at bottom part of the elbow) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (can barely move arm) and ARTHRALGIA (excruciating pain at bottom part of the elbow). At the time of the report, LIMB DISCOMFORT (can barely move arm) and ARTHRALGIA (excruciating pain at bottom part of the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications  were not reported  Treatment was not specified
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Nausea, Pain, Pyrexia
Clinical narrative: Terrible headache; Little bit nauseated; Just close to achiness; fever; Very sick; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Terrible headache), NAUSEA (Little bit nauseated), PAIN (Just close to achiness), PYREXIA (fever) and ILLNESS (Very sick) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced HEADACHE (Terrible headache), NAUSEA (Little bit nauseated), PAIN (Just close to achiness), PYREXIA (fever) and ILLNESS (Very sick). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Terrible headache), NAUSEA (Little bit nauseated), PAIN (Just close to achiness), PYREXIA (fever) and ILLNESS (Very sick) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No other medication reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Nausea, Overdose
Clinical narrative: Brain "fog"; Nausea; Headache; Invalid dose of 1ml of Moderna Vaccination; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (Invalid dose of 1ml of Moderna Vaccination), FEELING ABNORMAL (Brain "fog"), NAUSEA (Nausea) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milliliter. On 06-Apr-2021, the patient experienced OVERDOSE (Invalid dose of 1ml of Moderna Vaccination). On 07-Apr-2021, the patient experienced FEELING ABNORMAL (Brain "fog"), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, OVERDOSE (Invalid dose of 1ml of Moderna Vaccination) had resolved and FEELING ABNORMAL (Brain "fog"), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Fatigue, Headache, Myalgia
Clinical narrative: body aches; high fever; fatigue; muscle ache; extremely fatigued; very exhausted; headache; no appetite; while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DECREASED APPETITE (no appetite), SOMNOLENCE (while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes), PAIN (body aches), PYREXIA (high fever) and FATIGUE (fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), SOMNOLENCE (while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes), PYREXIA (high fever), FATIGUE (fatigue), MYALGIA (muscle ache), FATIGUE (extremely fatigued), FATIGUE (very exhausted) and HEADACHE (headache). On an unknown date, the patient experienced PAIN (body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (no appetite), SOMNOLENCE (while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes), PAIN (body aches), PYREXIA (high fever), FATIGUE (fatigue), MYALGIA (muscle ache), FATIGUE (extremely fatigued), FATIGUE (very exhausted) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) fever-102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Somnolence
Clinical narrative: body aches; high fever; fatigue; muscle ache; extremely fatigued; very exhausted; headache; no appetite; while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DECREASED APPETITE (no appetite), SOMNOLENCE (while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes), PAIN (body aches), PYREXIA (high fever) and FATIGUE (fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), SOMNOLENCE (while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes), PYREXIA (high fever), FATIGUE (fatigue), MYALGIA (muscle ache), FATIGUE (extremely fatigued), FATIGUE (very exhausted) and HEADACHE (headache). On an unknown date, the patient experienced PAIN (body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (no appetite), SOMNOLENCE (while he was driving back home from work, he had to pull over to the side of the road to sleep for about 30 minutes), PAIN (body aches), PYREXIA (high fever), FATIGUE (fatigue), MYALGIA (muscle ache), FATIGUE (extremely fatigued), FATIGUE (very exhausted) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) fever-102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of herpes zoster (shingles) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced herpes zoster (shingles). At the time of the report, herpes zoster (shingles) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Developed shingles 48 hours later. Concomitant product use and treatment information not provided by the reporter.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test negative, SARS-CoV-2 test negative
Clinical narrative: Antibodies test came back negative after almost a month from the second dose; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies test came back negative after almost a month from the second dose) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Leukemia.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies test came back negative after almost a month from the second dose). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Antibodies test came back negative after almost a month from the second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative (Negative) Negative.         No relevant concomitant medication was reported.  Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Erythema, Malaise, Peripheral swelling, Pruritus
Clinical narrative: Skin around shot become red; Left shoulder swollen; Arm swollen; Hard to feel around shot; left shoulder, left arm and wrist feels warm inside; Itchy feeling on face; Metallic taste; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy feeling on face), DYSGEUSIA (Metallic taste), ERYTHEMA (Skin around shot become red), SWELLING (Left shoulder swollen) and PERIPHERAL SWELLING (Arm swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PRURITUS (Itchy feeling on face) and DYSGEUSIA (Metallic taste). On 03-Apr-2021, the patient experienced ERYTHEMA (Skin around shot become red), SWELLING (Left shoulder swollen), PERIPHERAL SWELLING (Arm swollen), MALAISE (Hard to feel around shot) and SKIN WARM (left shoulder, left arm and wrist feels warm inside). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 27-Mar-2021, PRURITUS (Itchy feeling on face) and DYSGEUSIA (Metallic taste) had resolved. At the time of the report, ERYTHEMA (Skin around shot become red), SWELLING (Left shoulder swollen), PERIPHERAL SWELLING (Arm swollen), MALAISE (Hard to feel around shot) and SKIN WARM (left shoulder, left arm and wrist feels warm inside) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drugs include: Blood pressure pill
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm, Swelling
Clinical narrative: Skin around shot become red; Left shoulder swollen; Arm swollen; Hard to feel around shot; left shoulder, left arm and wrist feels warm inside; Itchy feeling on face; Metallic taste; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy feeling on face), DYSGEUSIA (Metallic taste), ERYTHEMA (Skin around shot become red), SWELLING (Left shoulder swollen) and PERIPHERAL SWELLING (Arm swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PRURITUS (Itchy feeling on face) and DYSGEUSIA (Metallic taste). On 03-Apr-2021, the patient experienced ERYTHEMA (Skin around shot become red), SWELLING (Left shoulder swollen), PERIPHERAL SWELLING (Arm swollen), MALAISE (Hard to feel around shot) and SKIN WARM (left shoulder, left arm and wrist feels warm inside). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 27-Mar-2021, PRURITUS (Itchy feeling on face) and DYSGEUSIA (Metallic taste) had resolved. At the time of the report, ERYTHEMA (Skin around shot become red), SWELLING (Left shoulder swollen), PERIPHERAL SWELLING (Arm swollen), MALAISE (Hard to feel around shot) and SKIN WARM (left shoulder, left arm and wrist feels warm inside) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drugs include: Blood pressure pill
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Pyrexia
Clinical narrative: Dizziness; Fever; Headache; pain at injection left; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache), VACCINATION SITE PAIN (pain at injection left) and CHILLS (chills) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at injection left), CHILLS (chills) and FATIGUE (fatigue). On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache), VACCINATION SITE PAIN (pain at injection left), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications  were not reported  Treatment was not specified
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Dizziness; Fever; Headache; pain at injection left; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache), VACCINATION SITE PAIN (pain at injection left) and CHILLS (chills) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at injection left), CHILLS (chills) and FATIGUE (fatigue). On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache), VACCINATION SITE PAIN (pain at injection left), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications  were not reported  Treatment was not specified
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Tooth infection
Clinical narrative: Dental infection; chills; Bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (Dental infection), CHILLS (chills) and MYALGIA (Bodyaches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event and Tooth extraction (7 or 8 teeth extracted) on 08-Apr-2021. Concomitant products included ADALIMUMAB (HUMIRA), METHOTREXATE, FOLIC ACID, VITAMIN D [VITAMIN D NOS] and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH INFECTION (Dental infection), CHILLS (chills) and MYALGIA (Bodyaches). At the time of the report, TOOTH INFECTION (Dental infection), CHILLS (chills) and MYALGIA (Bodyaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Invalid dose of 1ml of Moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (Invalid dose of 1ml of Moderna vaccine) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 06-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Invalid dose of 1ml of Moderna vaccine). On 06-Apr-2021, INCORRECT DOSE ADMINISTERED (Invalid dose of 1ml of Moderna vaccine) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Non significant follow up received on 26-MAY-2021, Patient route of administration is updated; Sender's Comments: This report refers to a case of Incorrect dose administered for mRNA-1273, lot # 044A21A, with no associated AEs.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Malaise, Rhinorrhoea
Clinical narrative: headache; felling sick; runny nose; cough; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felling sick), RHINORRHOEA (runny nose), COUGH (cough) and HEADACHE (headache) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced MALAISE (felling sick), RHINORRHOEA (runny nose) and COUGH (cough). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, MALAISE (felling sick), RHINORRHOEA (runny nose), COUGH (cough) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: Not Provided)  with no associated AEs.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: follow-up  were received on 24-MAY-2021 , HCP had stated that he have spoken to several people from Moderna who followed up. he was told this is not an expired vaccine use and it was viable.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: Not Provided)  with no associated AEs.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.            no concomitant and treatment drugs were provided.   This case was linked to MOD-2021-069726 (E2B Linked Report).; Sender's Comments:  MOD-2021-069726:First dose of vaccine case.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Pain in extremity, Vomiting
Clinical narrative: worn out/stayed in bed most of the day; Anxiety; Arm hurt for 3 days; Vomiting; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021. The most recent information was received on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), PAIN IN EXTREMITY (Arm hurt for 3 days), VOMITING (Vomiting) and FATIGUE (worn out/stayed in bed most of the day) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Food allergy (Egg white, Wheat, Turkey), Anxiety since December 1987, Pain and Allergy (allergies outside). Concomitant products included MARIJUANA for Anxiety and Pain.    On 07-Apr-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ANXIETY (Anxiety), PAIN IN EXTREMITY (Arm hurt for 3 days) and VOMITING (Vomiting). On 08-Apr-2021, the patient experienced FATIGUE (worn out/stayed in bed most of the day). On 07-Apr-2021, VOMITING (Vomiting) had resolved. On 09-Apr-2021, PAIN IN EXTREMITY (Arm hurt for 3 days) had resolved. At the time of the report, ANXIETY (Anxiety) and FATIGUE (worn out/stayed in bed most of the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Ostillococcinum for allergy before vaccination. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Initiative: communication regarding sending of form, believe she may have sent it, needs phone number. On 28-Apr-2021: Significant follow-up: New events added, medical history updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Headache, Myalgia
Clinical narrative: bone pain; Joint pain; muscles pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone pain), ARTHRALGIA (Joint pain), MYALGIA (muscles pain) and HEADACHE (headache  ) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BONE PAIN (bone pain), ARTHRALGIA (Joint pain), MYALGIA (muscles pain) and HEADACHE (headache  ). At the time of the report, BONE PAIN (bone pain), ARTHRALGIA (Joint pain), MYALGIA (muscles pain) and HEADACHE (headache  ) outcome was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema
Clinical narrative: Eczematous dermatitis; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (Eczematous dermatitis) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ECZEMA (Eczematous dermatitis). At the time of the report, ECZEMA (Eczematous dermatitis) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient called to report an adverse event and also had a concern: Received both the doses of Moderna vaccine. Received the 1st dose on 14FEB2021 and the 2nd dose on 14Mar2021. Short time before receiving the 2nd dose , developed eczema over patient's back and its persisting. The concern was, Is this symptom a reported side effect of Moderna vaccine and Did any other people reported similar symptoms after the Moderna vaccine? Patient did visited the Dermatologist who diagnosed the symptom as DERMATOGRAPHISIM and mentioned , it could be related to vaccine or due to Winter weather change. Dermatologist advised the patient to follow some treatment recommendation and follow up visit by month July if symptom persisting. Patient received both vaccine doses in the left arm. The lot # for 2nd dose vaccine vial mentioned as 013A21A and the expiration date as 20Aug2021. After receiving the 1st dose patient experienced the symptom of slight sore arm and the expiration date for the 1st dose vaccine vial mentioned as 01Jul2021. Gave consent for safety team and for HCP for follow up. Treatment Allegra, Cerave lotion for dry over, Dove soap   This case was linked to MOD-2021-069874 (Patient Link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fluid retention, Peripheral swelling
Clinical narrative: bot of his legs swelling; Water retention; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (bot of his legs swelling) and FLUID RETENTION (Water retention) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included AFib. Concurrent medical conditions included DVT (Edema or swelling in legs due yo DVT, worsened with time and experience continued after second dose) since 20-Mar-2021. Concomitant products included APIXABAN (ELIQUIS) for AFib, LISINOPRIL, METOPROLOL and HYDRALAZINE for Blood pressure management.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (bot of his legs swelling) and FLUID RETENTION (Water retention). The patient was treated with FUROSEMIDE ongoing since an unknown date for Water retention, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (bot of his legs swelling) and FLUID RETENTION (Water retention) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: Follow-up received: Added historical conditions.Updated patient demographics, indications of concomitant medications used and event outcome.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness/worse when she is sitting or lying down and then gets up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness/worse when she is sitting or lying down and then gets up) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 039A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (dizziness/worse when she is sitting or lying down and then gets up). At the time of the report, DIZZINESS (dizziness/worse when she is sitting or lying down and then gets up) had not resolved. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Had a rapid rapid heart beat for 5 or 6 secs; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Had a rapid rapid heart beat for 5 or 6 secs) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced HEART RATE INCREASED (Had a rapid rapid heart beat for 5 or 6 secs). At the time of the report, HEART RATE INCREASED (Had a rapid rapid heart beat for 5 or 6 secs) had resolved. Not Provided          Concomitant medications included blood pressure medication x2, asthma medication x2, thyroid medication  Treatment medication not reported. Action taken with mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: followup was received reporter contact information, email ID was added and second dose, start date was added and did not experience any side effects after second dose.